Interstitial pneumonia with autoimmune features

Interstitial pneumonia (IP) or interstitial lung disease (ILD) affect lung parenchyma, and if not treated will lead to irreparable lung damage. Classification of this group of diseases based on the etiology helps in diagnosing and managing these conditions. IP with autoimmune features (IPAF) is the...

Full description

Saved in:
Bibliographic Details
Main Authors: Uma Karjigi, Balebail G Dharmanand
Format: Article
Language:English
Published: SAGE Publishing 2021-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2021;volume=16;issue=5;spage=39;epage=46;aulast=Karjigi
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846097172194394112
author Uma Karjigi
Balebail G Dharmanand
author_facet Uma Karjigi
Balebail G Dharmanand
author_sort Uma Karjigi
collection DOAJ
description Interstitial pneumonia (IP) or interstitial lung disease (ILD) affect lung parenchyma, and if not treated will lead to irreparable lung damage. Classification of this group of diseases based on the etiology helps in diagnosing and managing these conditions. IP with autoimmune features (IPAF) is the term used for ILD with subtle signs of autoimmune disease but where there is insufficient evidence for it to be categorised as connective tissue disease. This review aims to look at the evidence available so far with regard to the concept of IPAF. It discusses the advantages and limitations of the current criteria, the epidemiology, clinical, radiological, serological features, management aspects, and prognosis of patients who fit into this particular entity.
format Article
id doaj-art-6758103db9b54ae6afba05d850cbab5a
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2021-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-6758103db9b54ae6afba05d850cbab5a2025-01-02T04:45:17ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012021-01-01165394610.4103/0973-3698.332977Interstitial pneumonia with autoimmune featuresUma KarjigiBalebail G DharmanandInterstitial pneumonia (IP) or interstitial lung disease (ILD) affect lung parenchyma, and if not treated will lead to irreparable lung damage. Classification of this group of diseases based on the etiology helps in diagnosing and managing these conditions. IP with autoimmune features (IPAF) is the term used for ILD with subtle signs of autoimmune disease but where there is insufficient evidence for it to be categorised as connective tissue disease. This review aims to look at the evidence available so far with regard to the concept of IPAF. It discusses the advantages and limitations of the current criteria, the epidemiology, clinical, radiological, serological features, management aspects, and prognosis of patients who fit into this particular entity.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2021;volume=16;issue=5;spage=39;epage=46;aulast=Karjigiautoantibodiesconnective tissue disease-interstitial lung diseasecyclophosphamideinterstitial pneumonia with autoimmune featuresmycophenolate mofetil
spellingShingle Uma Karjigi
Balebail G Dharmanand
Interstitial pneumonia with autoimmune features
Indian Journal of Rheumatology
autoantibodies
connective tissue disease-interstitial lung disease
cyclophosphamide
interstitial pneumonia with autoimmune features
mycophenolate mofetil
title Interstitial pneumonia with autoimmune features
title_full Interstitial pneumonia with autoimmune features
title_fullStr Interstitial pneumonia with autoimmune features
title_full_unstemmed Interstitial pneumonia with autoimmune features
title_short Interstitial pneumonia with autoimmune features
title_sort interstitial pneumonia with autoimmune features
topic autoantibodies
connective tissue disease-interstitial lung disease
cyclophosphamide
interstitial pneumonia with autoimmune features
mycophenolate mofetil
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2021;volume=16;issue=5;spage=39;epage=46;aulast=Karjigi
work_keys_str_mv AT umakarjigi interstitialpneumoniawithautoimmunefeatures
AT balebailgdharmanand interstitialpneumoniawithautoimmunefeatures